Gefitinib in Combination With Chemoradiation in Resectable Gastric Cancer

Update Il y a 4 ans
Reference: NCT00237900

Woman and Man

  • | Country :
  • Finland
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To assess safety, efficacy and explorative objectives of gefitinib in combination with chemoradiation in resectable gastric cancer


Inclusion criteria

  • Subjects With Resectable Local or Locally Advanced, Non-Metastatic (T2-T4, N0-N3, M0; Stages II and III) and Histologically-Confirmed Intestinal GC

Links